Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goldacre is a specialist venture capital firm and the investment arm of the Noé Group, focusing on the intersection of technology, real estate, and sustainable infrastructure. While primarily known for its investments in the 'Future of the City' and digital infrastructure, the firm plays a significant role in the life sciences sector by investing in and developing specialized real estate and data infrastructure required for biotech and healthcare innovation. Their portfolio includes major projects like Kao Data, which provides high-performance computing environments essential for genomic research and drug discovery. Goldacre bridges the gap between physical infrastructure and technological advancement, supporting the operational needs of the modern healthcare and life science industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goldacre.